Read + Share
Amedeo Smart
Independent Medical Education
Sloan SL, Renaldo KA, Long M, Chung JH, et al. Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma. PLoS One 2021;16:e0250839.PMID: 33989303
Email
LinkedIn
Facebook
Twitter
Privacy Policy